Inhibitory effects of hylligenin and quebrachitol isolated from mitrephora vulpina on platelet activating factor receptor binding and platelet aggregation

Molecules

Volumn 15, Issue 11, 2010, Pages 7840-7848

  Moharam, Bushra Abdulkarim ^a   Jantan, Ibrahim ^a   Jalil, Juriyati ^a   Shaari, Khozirah ^b  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Antiplatelet activity; Mitrephora vulpina; Phylligenin; Platelet activating factor (PAF)antagonist; Quebrachitol

Indexed keywords

ADENOSINE DIPHOSPHATE; ALKALOID; APORPHINE DERIVATIVE; ARACHIDONIC ACID; COLLAGEN; DRUG DERIVATIVE; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; INOSITOL; LIGNAN; LIRIODENINE; PHYLLIGENIN; QUEBRACHITOL; STIGMASTEROL; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL; ANNONACEAE; ARTICLE; CYTOLOGY; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN BINDING; RABBIT; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ALKALOIDS; ANIMALS; ANNONACEAE; APORPHINES; ARACHIDONIC ACID; COLLAGEN; HUMANS; INOSITOL; LIGNANS; PLATELET AGGREGATION; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; RABBITS; RECEPTORS, G-PROTEIN-COUPLED; STIGMASTEROL;

EID: 78649492678     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15117840     Document Type: Article

References (31)

1. Vargaftig, B.B.; Braquet, P.G. PAF-acether today: relevance for acute experimental anaphylaxis. Br. Med. Bull. 1987, 43, 312-335.
2. Mallet, A.T.; Cunningham, F.M. Structural identification of platelet activating factor in psoriatic scale. Biochem. Biophys. Res. Commun. 1985,126, 192-198.
3. Braquet, P.; Hosford, D. Ethnopharmacology and the development of natural PAF antagonist as therapeutic agents. J. Ethnopharmacol. 1991, 32, 135-139.
4. Ross R. The pathogenesis of artherosclerosis: a perspective for the 90s. Nature 1993, 362, 801-809.
5. Arita, H.; Nakano, T.; Hansaki, K. Thromboxane A2, its generation and role in platelet activation. Prog. Lipid Res. 1989, 28, 273-301.
6. Lefkovits, J. Recent advances in antiplatelet therapy. Aust. Prescr. 1996, 19, 98-100.
7. Gresele, P.; Agnelli, G. Novel approaches to the treatment of thrombosis. Trends Pharmacol. 2002, 23, 25-32.
8. Weerasooriya, A.D.; Saunders, R.M.K. The genus Mitrephora (Annonaceae) in Cambodia, Laos, and Vietnam. Syst. Bot. 2005, 30, 248-262.
9. Lee, N.H.S.; Xu, Y.J.; Goh, S.H. 5-Oxonoraporphines from Mitrephora cf. Maingayi. J. Nat. Prod. 1999, 62, 1158-1159.
10. Supudompol, B.; Chaowasku, T.; Kingfang, K.; Burud, K.; Wongseripipatana, S.; Likhitwitayawuid, K. A new pimarane from Mitrephora tomentosa. Nat. Prod. Res. 2004, 18, 387-390.
11. Li, C.; Lee, D.; Graf, T.N.; Phifer, S.S.; Nakanishi, Y.; Burgess, J.P.; Riswan, S.; Setyowati, F.M.; Saribi, A.M.; Soejarto, D.D.; Farnsworth, N.R.; Falkinham, J.O., 3rd; Kroll, D.J.; Kinghorn, A.D.; Wani, M.C.; Oberlies, N.H.; A hexacyclic ent-trachylobane diterpenoid possessing an oxetane ring from Mitrephora glabra. Org. Lett. 2005, 7, 5709-5712.
12. Yu, R.; Li, B.G.; Ye, Q.; Zhang, G.L. A novel alkaloid from Mitrephora maingayi. Nat. Prod. Res. 2005, 19, 359-362.
13. Deepralard, K.; Pengsuparp, T.; Moriyasu, M.; Kawanishi, K.; Suttisri, R. Chemical constituents of Mitrephora maingayi. Biochem. Syst. Ecol. 2007, 35, 696-699.
14. Ge, F.; Tang, C.P.; Ye, Y. Lignanamides and sesquiterpenoids from stems of Mitrephora thorelii. Helv. Chim. Acta. 2008, 91, 1023-1030.
15. Li, C.; Lee, D.; Graf, T.N.; Phifer, S.S.; Nakanishi, Y.; Riswan, S. Bioactive constituents of the stem bark of Mitrephora glabra. J. Nat. Prod. 2009, 72, 1949-1953.
16. Mueller, D.; Davis, R.A.; Duffy, S.; Avery, V.M.; Camp, D.; Quinn, R.J. Antimalarial activity of azafluorenone alkaloids from the Australian tree Mitrephora diversifolia. J. Nat. Prod. 2009, 72, 1538-1540.
17. Meng, D.H.; Xu, Y.P.; Chen, W.L.; Zou, J.; Lou, L.G.; Zhao, W.M.; Anti-tumour clerodane-type diterpenes from Mitrephora thorelii. J. Asian Nat. Prod. Res. 2007, 9, 679-684.
18. Zgoda, J.R.; Freyer, A.J.; Killmer, L.B.; Porter, J.R. Polyacetylene carboxylic acids from Mitrephora celebica. J. Nat. Prod. 2001, 64, 1348-1349.
19. Hsu, C.C.; Dobberstein, R.H.; Cordell, G.A.; Farnsworth, N.R. Isolation of lauterine and oxoputerine, two new oxoaporphine alkaloids from Guatteria elata. Lloydia 1977, 40, 152-156.
20. Goh, S.H; Jantan, I. Aporphine alkaloids of Aromadendron elegans. Phytochemistry 1992, 31, 2495-2498.
21. Kongduang, D.; Wungsintaweekul, J.; De-Eknamkul, W. Biosynthesis of [beta]-sitosterol and stigmasterol proceeds exclusively via the mevalonate pathway in cell suspension cultures of Croton stellatopilosus. Tetrahedron Lett. 2008, 49, 4067-4072.
22. Diaz, M.; Gonzalez, A.; Castro-Gamboa, I.; Gonzalez, D.; Rossini, C. First record of lquebrachitol in Allophylus edulis (Sapindaceae). Carbohyd. Res. 2008, 343, 2699-2700.
23. Lim, H.; Lee, J.G.; Lee, S.H.; Kim, Y.S.; Kim, H.P. Anti-inflammatory activity of phylligenin, a lignan from the fruits of Forsythia koreana, and its cellular mechanism of action. J. Ethnopharmacol. 2008, 118, 113-117.
24. Jantan, I.; Pisar, M.M.; Idris, M.S.; Taher, M.; Mat Ali, R. In vitro inhibitory effect of rubraxanthone isolated from Garcinia parvifolia on platelet-activating factor receptor binding. Planta Med. 2002, 68, 1133-1134.
25. Iwakami, S.; Wu, J.B.; Ebizuka, Y.; Sankawa, U. Platelet activating factor (PAF) antagonists contained in medicinal plants: Lignans and sesquiterpenes. Chem. Pharm. Bull. 1992, 40, 1196-1198.
26. Aurousseau, M.; Lagrange, E.; Roquet, F. Study of some pharmacodynamic properties of a laxative substance of plant origin: Quebrachitol. Therapie 1964, 19, 1071-1083.
27. Kim, A.R.; Zou, Y.N.; Park, T.H.; Shim, K.H.; Kim, M.S.; Kim, N.D. Active components from Artemisia iwayomogi displaying ONOO- scavenging activity. Phytother. Res. 2004, 18, 1-7.
28. Nobre Junior, H.V.; Cunha, G.M.A.; Moraes, M.O.; Luciana, M.F.D.; Oliveira, R.A.; Maia, F.D. Quebrachitol (2-O-methyl-l-inositol) attenuates 6-hydroxydopamine-induced cytotoxicity in rat fetal mesencephalic cell cultures. Food Chem. Toxicol. 2006, 44, 1544-1551.
29. Loyd, J.; Bochner, F. Aspirin: how low is the dose? Aust. Prescr. 1996, 19, 79-81.
30. Valone, F.H.; Coles, E.; Reinhold, V.R.; Goetzl, E.J. Specific binding of phospholipid plateletactivating factor by human platelets. J. Immunol. 1982, 129, 1637-1641.
31. Jantan, I.; Raweh, S.M.; Yasin, Y.H.M.; Murad, S. Antiplatelet activity of aporphine and phenanthrenoid alkaloids from Aromadendron elegans blume. Phytother. Res. 2006, 20, 493-496.